CRSP · CRISPR Therapeutics AG
Market Cap
$5.58B
Shares
96.69M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-01-22 | RAJU PRASAD | Officer | 34,972 | 2026-01-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-06 | RAJU PRASAD | Officer | 29,700 | 2026-01-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-22 | RAJU PRASAD | Officer | 10,000 | 2025-12-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-04-15 | SAMARTH KULKARNI | Officer, Director | 19,582 | 2024-04-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-03-22 | PHUONG KHANH MORROW | Officer | 50,767 | 2024-03-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-03-15 | SAMARTH KULKARNI | Officer, Director | 20,000 | 2024-03-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-02-15 | SAMARTH KULKARNI | Officer, Director | 20,000 | 2024-02-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-01-29 | SAMARTH KULKARNI | Officer, Director | 50,000 | 2024-01-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-01-16 | SAMARTH KULKARNI | Officer, Director | 20,000 | 2024-01-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-05-30 | SAMARTH KULKARNI | Officer, Director | 25,000 | 2023-05-30 | Morgan Stanley Smith Barney LLC |
| 2023-05-10 | Brendan Smith | Officer | 9,583 | 2023-05-10 | Morgan Stanley Smith Barney LLC |
| 2023-04-25 | SAMARTH KULKARNI | Officer, Director | 25,000 | 2023-04-25 | Morgan Stanley Smith Barney LLC |
Showing 1–12 of 12 filings
Key facts
CIK
1674416
CUSIP
H17182108
13F (30d)
385 filings
362 filers
Visit website
Investor relations